| 1AD5 | A:82-145; B:82-145 | SRC FAMILY KINASE HCK-AMP-PNP COMPLEX |
| 1BU1 | A:; B:; C:; D:; E:; F: | SRC FAMILY KINASE HCK SH3 DOMAIN |
| 1QCF | A:80-145 | CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY-SELECTIVE TYROSINE KINASE INHIBITOR |
| 2C0I | A:59-120; B:59-120 | SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983 |
| 2C0O | A:59-120; B:59-120 | SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041 |
| 2C0T | A:59-120; B:59-120 | SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359 |
| 2HCK | A:82-145; B:82-145 | SRC FAMILY KINASE HCK-QUERCETIN COMPLEX |
| 3REA | B:; D: | HIV-1 NEF PROTEIN IN COMPLEX WITH ENGINEERED HCK-SH3 DOMAIN |
| 3VRY | A:85-146; B:85-146 | CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL-CYCLOPENTANE |
| 3VRZ | A:85-146; B:85-146 | CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)PHENYL]-3-BENZYLUREA |
| 3VS0 | A:85-146; B:85-146 | CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR N-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL) PHENYL]BENZAMIDE |
| 3VS1 | A:85-146; B:85-146 | CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)PHENYL]-3-PHENYLUREA |
| 3VS2 | A:85-146; B:85-146 | CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[CIS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE |
| 3VS3 | A:85-146; B:85-146 | CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE |
| 3VS4 | A:85-146; B:85-146 | CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 5-(4-PHENOXYPHENYL)-7-(TETRAHYDRO-2H-PYRAN-4-YL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE |
| 3VS5 | A:85-146; B:85-146 | CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-(1-METHYLPIPERIDIN-4-YL)-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE |
| 3VS6 | A:85-146; B:85-146 | CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR TERT-BUTYL {4-[4-AMINO-1-(PROPAN-2-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]-2-METHOXYPHENYL}CARBAMATE |
| 4HCK | A: | HUMAN HCK SH3 DOMAIN, NMR, 25 STRUCTURES |
| 4LUD | A:85-146; B:85-146 | CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH THE FLUORESCENT COMPOUND SKF86002 |
| 5HCK | A: | HUMAN HCK SH3 DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE |
)
)